103 related articles for article (PubMed ID: 15324576)
1. [Significance of C-reaction protein for differential diagnosis of fever after chemotherapy on children with acute lymphoblastic leukemia].
Fang CQ; Tang YM; Li HF; Song H; Shi SW; Yang SL; Xu WQ
Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):536-7. PubMed ID: 15324576
[No Abstract] [Full Text] [Related]
2. Aseptic meningitis in a child after systemic treatment with high dose cytarabine.
Pease CL; Horton TM; McClain KL; Kaplan SL
Pediatr Infect Dis J; 2001 Jan; 20(1):87-9. PubMed ID: 11176579
[TBL] [Abstract][Full Text] [Related]
3. Cholelithiasis and choledocholithiasis after sequential cytarabine and asparaginase.
Sandoval C; Katz B; Stringel G; Jayabose S; Lebovics E
J Pediatr Hematol Oncol; 2003 Aug; 25(8):637-9. PubMed ID: 12902918
[TBL] [Abstract][Full Text] [Related]
4. Optimizing antimetabolite-based chemotherapy for the treatment of childhood acute lymphoblastic leukaemia.
Estlin EJ; Lowis SP; Hall AG
Br J Haematol; 2000 Jul; 110(1):29-40. PubMed ID: 10930977
[No Abstract] [Full Text] [Related]
5. Ara-C fever and infections after high-dose ara-C treatment in pediatric lymphoid malignancies.
Ek T; Pinkava M; Abrahamsson J
J Pediatr Hematol Oncol; 2005 Jul; 27(7):364-9. PubMed ID: 16012325
[TBL] [Abstract][Full Text] [Related]
6. Two cases of cytarabine syndrome successfully resolved by desensitization.
Lim KH; Kim JY; Kang MG; Park HK; Kang HR
J Investig Allergol Clin Immunol; 2015; 25(1):80-2. PubMed ID: 25898709
[No Abstract] [Full Text] [Related]
7. [Cytosine arabinoside and VM-26 in induction treatment, failures and recurrences of childhood acute lymphoblastic leukemias].
Navajas Gutiérrez A; Bezanilla Regato JL; Moya Calderón E; Piñán MA
An Esp Pediatr; 1988 Oct; 29 Suppl 34():91-3. PubMed ID: 3214046
[No Abstract] [Full Text] [Related]
8. [Corneal toxicity of cytarabine. Apropos of a case].
Bursztyn J; Boccara JF; Paillassou B; Bavoux F
Ophtalmologie; 1989; 3(3):229-30. PubMed ID: 2641118
[TBL] [Abstract][Full Text] [Related]
9. Acral erythema with bullous formation: a side effect of chemotherapy in a child with acute lymphoblastic leukemia.
Aytaç S; Gümrük F; Cetin M; Tuncer M; Yetgin S
Turk J Pediatr; 2010; 52(2):211-4. PubMed ID: 20560263
[TBL] [Abstract][Full Text] [Related]
10. Effect of genetic alterations of cytarabine- metabolizing enzymes in childhood acute lymphoblastic leukemia.
Banklau C; Jindadamrongwech S; Sawangpanich R; Apibal S; Hongeng S; Paisooksantivatana K; Pakakasama S
Hematol Oncol Stem Cell Ther; 2010; 3(3):103-8. PubMed ID: 20890066
[TBL] [Abstract][Full Text] [Related]
11. Diffuse cerebral vasospasm with infarct after intrathecal cytarabine in childhood leukemia.
Yoon JH; Yoon JY; Park HJ; Son MH; Kim SH; Kim W; Kim HJ; Lee SH; Park BK
Pediatr Int; 2014 Dec; 56(6):921-924. PubMed ID: 25521979
[TBL] [Abstract][Full Text] [Related]
12. [Acute lymphoblastic leukemia in childhood. A 10-year experience with the DFCI 81-01 protocol].
de Lacerda AF; Chagas M; Neto A; Vieira E; Ribeiro MJ; Pereira F; Ambrósio A; Sousinha M
Acta Med Port; 1999; 12(7-11):287-92. PubMed ID: 10707467
[TBL] [Abstract][Full Text] [Related]
13. Acute basal ganglia necrosis associated with cytarabine therapy.
Sirvent N; Monpoux F; Benet L; Richelme C; Mariani R; Diaine B
Med Pediatr Oncol; 1998 May; 30(5):308. PubMed ID: 9544229
[No Abstract] [Full Text] [Related]
14. Mercaptopurine-induced fever: hypersensitivity reaction in a patient with acute lymphoblastic leukemia.
Chen LJ; Nightingale G; Baer MR
Pharmacotherapy; 2010 Jan; 30(1):113. PubMed ID: 20030482
[TBL] [Abstract][Full Text] [Related]
15. High-dose cytarabine-based therapy in adults with acute lymphoblastic leukemia.
Feldman EJ
Leuk Res; 2000 Mar; 24(3):189-91. PubMed ID: 10739000
[No Abstract] [Full Text] [Related]
16. "Reaction to cytarabine (Ara-C) treatment in patients with concurrent Staphylococcus aureus infection: a coalition between Ara-C and superantigens?".
Savaşan S; Warrier I; Can E; Can M; Gedikoğlu G
Med Pediatr Oncol; 1998 Apr; 30(4):263-4. PubMed ID: 9473764
[No Abstract] [Full Text] [Related]
17. Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia.
Pakakasama S; Kanchanakamhaeng K; Kajanachumpol S; Udomsubpayakul U; Sirachainan N; Thithapandha A; Hongeng S
Ann Hematol; 2007 Aug; 86(8):609-11. PubMed ID: 17323057
[No Abstract] [Full Text] [Related]
18. [Skin toxicity associated with bolus infusion of low-dose cytarabine].
Takeuchi M; Tanizawa A; Fukumoto Y; Kikawa Y; Mayumi M
Rinsho Ketsueki; 2001 Mar; 42(3):216-7. PubMed ID: 11345785
[TBL] [Abstract][Full Text] [Related]
19. Isolated decrease in factor V in children treated by 6-Mercaptopurine for acute lymphoblastic Leukemia.
Filhon B; Dumesnil C; Van Dreden P; Schneider P; Vasse M; Vannier JP
Thromb Res; 2014 Nov; 134(5):1164-6. PubMed ID: 25204998
[No Abstract] [Full Text] [Related]
20. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia.
Evans WE; Relling MV; Rodman JH; Crom WR; Boyett JM; Pui CH
N Engl J Med; 1998 Feb; 338(8):499-505. PubMed ID: 9468466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
